These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 18811679)

  • 21. The P300 event-related brain potential as a neurobiological endophenotype for substance use disorders: a meta-analytic investigation.
    Euser AS; Arends LR; Evans BE; Greaves-Lord K; Huizink AC; Franken IH
    Neurosci Biobehav Rev; 2012 Jan; 36(1):572-603. PubMed ID: 21964481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substance dependence and externalizing psychopathology in adolescent boys with small, average, or large P300 event-related potential amplitude.
    Carlson SR; Katsanis J; Iacono WG; Mertz AK
    Psychophysiology; 1999 Sep; 36(5):583-90. PubMed ID: 10442026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P300 amplitude, externalizing psychopathology, and earlier- versus later-onset substance-use disorder.
    Carlson SR; McLarnon ME; Iacono WG
    J Abnorm Psychol; 2007 Aug; 116(3):565-77. PubMed ID: 17696712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The P300 event-related potential and its possible role as an endophenotype for studying substance use disorders: a review.
    Singh SM; Basu D
    Addict Biol; 2009 Jul; 14(3):298-309. PubMed ID: 18811679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Event-related potentials in substance use disorders: a narrative review based on articles from 1984 to 2012.
    Campanella S; Pogarell O; Boutros N
    Clin EEG Neurosci; 2014 Apr; 45(2):67-76. PubMed ID: 24104954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Electrophysiology and schizophrenic vulnerability: the P300 component as endophenotype candidate?].
    Cermolacce M; Micoulaud JA; Naudin J; Vion-Dury J
    Encephale; 2011 Oct; 37(5):353-60. PubMed ID: 22032278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The utility of an endophenotype approach in overcoming the difficulties in bipolar and schizophrenia genetics].
    Ozer S; Ayhan Y; Uluşahin A
    Turk Psikiyatri Derg; 2004; 15(2):125-37. PubMed ID: 15208768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral disinhibition and the development of early-onset addiction: common and specific influences.
    Iacono WG; Malone SM; McGue M
    Annu Rev Clin Psychol; 2008; 4():325-48. PubMed ID: 18370620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substance use disorders, externalizing psychopathology, and P300 event-related potential amplitude.
    Iacono WG; Malone SM; McGue M
    Int J Psychophysiol; 2003 May; 48(2):147-78. PubMed ID: 12763572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiological indices of biased cognitive processing of substance-related cues: a meta-analysis.
    Littel M; Euser AS; Munafò MR; Franken IH
    Neurosci Biobehav Rev; 2012 Sep; 36(8):1803-16. PubMed ID: 22613258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The concept of endophenotypes in psychiatric diseases meeting the expectations?
    Puls I; Gallinat J
    Pharmacopsychiatry; 2008 Sep; 41 Suppl 1():S37-43. PubMed ID: 18756419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurological soft signs as candidate endophenotypes for schizophrenia: a shooting star or a Northern star?
    Chan RC; Gottesman II
    Neurosci Biobehav Rev; 2008 Jul; 32(5):957-71. PubMed ID: 18462797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Event-related EEG and evoked potential investigations in clinical practice].
    Rajna P; Hidasi Z; Waldemar S
    Ideggyogy Sz; 2005 Nov; 58(11-12):380-92. PubMed ID: 16491563
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.